Literature DB >> 2463114

Sensitization of human keratinocytes to killing by parvovirus H-1 takes place during their malignant transformation but does not require them to be tumorigenic.

Y Q Chen1, M C Tuynder, J J Cornelis, P Boukamp, N E Fusenig, J Rommelaere.   

Abstract

To investigate the antineoplastic activity of parvoviruses, proliferating normal human epidermal cells and a series of established keratinocyte cell lines derived from squamous cell carcinomas or transformed in vitro, were compared for the outcome of H-1 virus infection. All established keratinocyte cell lines were more sensitive to killing by H-1 virus than normal epidermal cells, although to varying extents. Using a step-wise procedure for malignant transformation in vitro, we found that sensitization of transformed epidermal cells to H-1 virus can be dissociated from the acquisition of a tumorigenic phenotype. Thus, spontaneously- or SV40-immortalized human keratinocytes were moderately and highly sensitive to H-1 virus, respectively, and could be made tumorigenic by Harvey-ras oncogene transfection without a major change in their susceptibility to the virus. The capacity of human keratinocytes for replicating and expressing H-1 virus DNA appears to be a revealer of cellular alterations that take place in at least some pathways to malignant transformation but that may be insufficient to confer a tumorigenic potential.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463114     DOI: 10.1093/carcin/10.1.163

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Initiation of transcription from the minute virus of mice P4 promoter is stimulated in rat cells expressing a c-Ha-ras oncogene.

Authors:  P Spegelaere; B van Hille; N Spruyt; S Faisst; J J Cornelis; J Rommelaere
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.

Authors:  Karsten Geletneky; Irina Kiprianova; Ali Ayache; Regina Koch; Marta Herrero Y Calle; Laurent Deleu; Clemens Sommer; Nadja Thomas; Jean Rommelaere; Jörg R Schlehofer
Journal:  Neuro Oncol       Date:  2010-03-18       Impact factor: 12.300

3.  Identification of a novel cellular TPR-containing protein, SGT, that interacts with the nonstructural protein NS1 of parvovirus H-1.

Authors:  C Cziepluch; E Kordes; R Poirey; A Grewenig; J Rommelaere; J C Jauniaux
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  The parvoviral capsid controls an intracellular phase of infection essential for efficient killing of stepwise-transformed human fibroblasts.

Authors:  Justin Paglino; Peter Tattersall
Journal:  Virology       Date:  2011-05-20       Impact factor: 3.616

5.  Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein.

Authors:  F Dupont; L Tenenbaum; L P Guo; P Spegelaere; M Zeicher; J Rommelaere
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Susceptibility of human cells to killing by the parvoviruses H-1 and minute virus of mice correlates with viral transcription.

Authors:  J J Cornelis; Y Q Chen; N Spruyt; N Duponchel; S F Cotmore; P Tattersall; J Rommelaere
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Restriction of porcine parvovirus replication in nonpermissive cells.

Authors:  K Oraveerakul; C S Choi; T W Molitor
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17.

Authors:  C Walz; J R Schlehofer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 9.  Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.

Authors:  Assia L Angelova; Karsten Geletneky; Jürg P F Nüesch; Jean Rommelaere
Journal:  Front Bioeng Biotechnol       Date:  2015-04-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.